{"DataElement":{"publicId":"3226218","version":"1","preferredName":"Minimal Residual Disease Analysis At End Second Course Leukemic Cell Present Number","preferredDefinition":"The percentage value of the leukemic cells detected by flow cytometry in the analysis of a remainder of the leukemic cells after the second course of primary therapy.","longName":"3226217v1.0:3226200v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3226217","version":"1","preferredName":"Minimal Residual Disease Analysis At End Second Course","preferredDefinition":"remainder of a tumor or a neoplasm/cancer after primary, potentially curative therapy._Analysis; examination and interpretation._Used to indicate position, location, or state (American Heritage Dictionary)_The point or place at which something terminates in time, space, or extent._Coming next after the first in position in space or time or degree or magnitude._A period of protocol-prescribed activity or intervention.","longName":"3226195v1.0:3226220v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3226195","version":"1","preferredName":"Minimal Residual Disease Analysis","preferredDefinition":"remainder of a tumor or a neoplasm/cancer after primary, potentially curative therapy.:Analysis; examination and interpretation.","longName":"C3896:C25391","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Measurable Residual Disease","conceptCode":"C3896","definition":"Evidence for remaining tumor following primary treatment that is only apparent using highly sensitive techniques.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Analysis","conceptCode":"C25391","definition":"Examination and interpretation; the process of identifying an issue to be understood and addressed, modelling the issue, investigating the model results, interpreting the results, and possibly making a recommendation. The concept also refers to the examination and study of a whole in terms of the parts composing it.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A059F8F3-75FF-D2EB-E040-BB89AD43388D","latestVersionIndicator":"Yes","beginDate":"2011-04-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-07","modifiedBy":"ONEDATA","dateModified":"2011-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3226220","version":"1","preferredName":"At End Second Course","preferredDefinition":"Used to indicate position, location, or state (American Heritage Dictionary):The point or place at which something terminates in time, space, or extent.:Coming next after the first in position in space or time or degree or magnitude.:A period of protocol-prescribed activity or intervention.","longName":"C25427:C25496:C25666:C25379","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"At","conceptCode":"C25427","definition":"Used to indicate position, location, or state.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"End","conceptCode":"C25496","definition":"The point or place at which something terminates in time, space, or extent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Second","conceptCode":"C25666","definition":"Coming next after the first in position in space or time or degree or magnitude.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Course","conceptCode":"C25379","definition":"Passage through time; duration; a systematic or/and orderly succession; a sequence, e.g. course of treatment; a mode of action or behavior; natural development, typical manner of proceeding.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A05AE761-F346-00AE-E040-BB89AD4354EE","latestVersionIndicator":"Yes","beginDate":"2011-04-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-07","modifiedBy":"ONEDATA","dateModified":"2011-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A05A6B04-5B46-8EEE-E040-BB89AD4352C5","latestVersionIndicator":"Yes","beginDate":"2011-04-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-07","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Released per approval from T.Davidsen. mc 4/18/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3226200","version":"1","preferredName":"Leukemic Cell Present Number","preferredDefinition":"Malignant hematopoietic cell originating in the clonal proliferation of myeloid or lymphoid precursor that undergoes an aberrant and poorly regulated process of organogenesis resulted in arrested maturation and cell capacity for unlimited self-renewal._Being or existing in a specified place or at the specified time._Number; a concept of quantity derived from zero and units; a numeral or string of numerals that is used for identification.","longName":"3226200v1.0","context":"NCIP","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","unitOfMeasure":"%","minLength":"3","maxLength":"6","minValue":"0.01","maxValue":"100","decimalPlace":"2","format":"999.99","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3226199","version":"1","preferredName":"Leukemic Cell Present Number","preferredDefinition":"Malignant hematopoietic cell originating in the clonal proliferation of myeloid or lymphoid precursor that undergoes an aberrant and poorly regulated process of organogenesis resulted in arrested maturation and cell capacity for unlimited self-renewal.:Being or existing in a specified place or at the specified time.:Number; a concept of quantity derived from zero and units; a numeral or string of numerals that is used for identification.","longName":"C25553:C25626:C25337","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Leukemic Cell","conceptCode":"C25553","definition":"Malignant hematopoietic cell originating in the clonal proliferation of myeloid or lymphoid precursor that undergoes an aberrant and poorly regulated process of organogenesis resulted in arrested maturation and cell capacity for unlimited self-renewal.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Number","conceptCode":"C25337","definition":"A numeral or string of numerals expressing value, quantity, or identification.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A059F8F3-7646-D2EB-E040-BB89AD43388D","latestVersionIndicator":"Yes","beginDate":"2011-04-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-07","modifiedBy":"ONEDATA","dateModified":"2011-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A059F8F3-7657-D2EB-E040-BB89AD43388D","latestVersionIndicator":"Yes","beginDate":"2011-04-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-07","modifiedBy":"COOPERM","dateModified":"2011-04-18","changeDescription":"Released per approval of T.Davidsen. mc 4/18/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5650570","version":"1","longName":"TARGET","context":"OCG","ClassificationSchemeItems":[{"publicId":"5650572","version":"1","longName":"AML","context":"OCG"}]}],"AlternateNames":[{"name":"OCG","type":"USED_BY","context":"OCG"}],"ReferenceDocuments":[{"name":"MRD (% of nucleated cells) de","type":"Preferred Question Text","description":"MRD (% of nucleated cells) detected by flow cytometry at end of course 2","url":null,"context":"NCIP"},{"name":"Original TARGET Question","type":"Alternate Question Text","description":"MRD% at end of course 2","url":null,"context":"NCIP"},{"name":"MRD reference:  Blood. 2012 Aug 23;120(8):1581-8.","type":"REFERENCE","description":"MRD reference:  Blood. 2012 Aug 23;120(8):1581-8.","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A05A6B04-5B63-8EEE-E040-BB89AD4352C5","latestVersionIndicator":"Yes","beginDate":"2011-04-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-07","modifiedBy":"COOPERM","dateModified":"2017-02-02","changeDescription":"Released per approval from T.Davidsen. mc 4/18/11 Updated definition and question text per request by Tanja. mc 12/23/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}